# Waterman Ventures

> Waterman Ventures is a VC fund in New York backing Software and Biopharma. See 11 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 11
- Last investment: Jan 2026
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/waterman-ventures/
- Website: http://www.waterman-ventures.com
- Facebook: https://www.facebook.com/watermanventures/

Waterman Ventures is a community of Brown University alumni, investors, entrepreneurs, and innovation enthusiasts.

## Contacts

5 contacts available for Waterman Ventures. Shizune tracks 5 team members at Waterman Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/waterman-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 3 | 27% |
| Biopharma | 2 | 18% |
| Biotechnology | 2 | 18% |
| Information Technology | 2 | 18% |
| Sensor | 1 | 9% |

24 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 4 | 36% |
| Series A | 3 | 27% |
| Series F | 1 | 9% |
| Funding Round | 1 | 9% |
| Venture - Series Unknown | 1 | 9% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 6 | 55% |
| The Netherlands | 2 | 18% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Dave Fan | Senior Principal, Investment Committee Member | 0 | https://shizune.co/investors/profile/david-fan-f9ca |
| Dave Fan | Senior Principal, Investment Committee Member | 0 | https://shizune.co/investors/profile/dave-fan |
| Lawrence Ham | Fellow | 0 | https://shizune.co/investors/profile/lawrence-ham |
| Ludwig Pierre Schulze | Managing Partner | 52 | https://shizune.co/investors/profile/ludwig-schulze |
| Ronak Massand | Venture Fellow | 0 | https://shizune.co/investors/profile/ronak-massand |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Qualinx | Qualinx is the wireless radio company with its main focus on radios for portable devices in the Internet-of-Things applications.Founded in 2015 as a spin out of the well-known Technical University of Delft (TU Delft), Qualinx commercializes the innovative and tested Digital/Discrete-Time RF (DRF) technology for different ultra-low-powerradio products. The main idea of the DRF technology is digital and digital-like implementation of RF/Analog blocks by new circuit, system, and architectural innovations. This enables full integration of high quality radios in CMOS with the lowest power consumption and a small die size.With this capability, Qualinx is addressing the need for radio solutions with long battery life, driven by the portable IoT, wearable, and mobile applications in volume production. Qualinx DRF technology suits well for Bluetooth, ZigBee, Thread, GNSS, and other IoT standards demanding an ultra-low-power consumption. With investment of European funding and support of TU Delft, extensive developments have already been done to offer CMOS radios and their related IPs. | $23.4M | Venture - Series Unknown | Jan 06, 2026 |  |
| Alveron Pharma | Alveron Pharma develops treatment for hemorrhagic stroke, a severe unmet medical need. Alveron’s drug OKL-1111 strongly reduces hematoma expansion in a mouse model of intracranial hemorrhage. As an injection solution that is ready to use, OKL-1111 is being developed to do away with a laborious pre-treatment process. | $5.3M | Seed | Dec 06, 2024 |  |
| Qualinx | Qualinx is the wireless radio company with its main focus on radios for portable devices in the Internet-of-Things applications.Founded in 2015 as a spin out of the well-known Technical University of Delft (TU Delft), Qualinx commercializes the innovative and tested Digital/Discrete-Time RF (DRF) technology for different ultra-low-powerradio products. The main idea of the DRF technology is digital and digital-like implementation of RF/Analog blocks by new circuit, system, and architectural innovations. This enables full integration of high quality radios in CMOS with the lowest power consumption and a small die size.With this capability, Qualinx is addressing the need for radio solutions with long battery life, driven by the portable IoT, wearable, and mobile applications in volume production. Qualinx DRF technology suits well for Bluetooth, ZigBee, Thread, GNSS, and other IoT standards demanding an ultra-low-power consumption. With investment of European funding and support of TU Delft, extensive developments have already been done to offer CMOS radios and their related IPs. | $8.5M | Series A | Feb 21, 2023 |  |
| Runwise | Runwise is a wireless control, sensor network, and software platform to better operate heating systems. Its mission is to enable buildings to run more efficiently using intelligent and easy-to-install wireless hardware and software.The company's users can reduce heating expenses and carbon emissions thanks to the network's management ofheating and boiler systems, which also avoids under- and overheating and gives a verifiable online record of both. | $19M | Series A | Nov 03, 2022 |  |
| Quiltt | Quiltt enables financial innovators to access the best account aggregation and transaction enrichment providers through one lightweight integration and one simple contract. Our mission is to unlock the next wave of fintech innovation by removing technical and commercial barriers to build with financial data. | $3M | Seed | Jul 11, 2022 |  |
| Satellite Bio | Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases. | $82.5M |  | Mar 07, 2022 |  |
| Satellite Bio | Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases. | $82.5M | Series A | Mar 07, 2022 |  |
| JumpCloud | JumpCloud is an open directory platform for secure, frictionless access from any device to any resource, anywhere. JumpCloud’s mission is to Make Work Happen, providing simple, secure access to corporate technology resources from any device, or any location. The JumpCloud Directory Platform gives IT, security operations, and DevOps a single,cloud-based solution to control and manage employee identities, their devices, and apply Zero Trust principles. JumpCloud has a global user base of more than 100,000 organizations, with over 3,000 customers including Cars.com, GoFundMe, Grab, ClassPass, Uplight, Beyond Finance, and Foursquare. JumpCloud is backed by BlackRock, General Atlantic, OpenView, and Foundry Group. | $66M | Series F | Oct 19, 2021 |  |
| Alveron Pharma | Alveron Pharma develops treatment for hemorrhagic stroke, a severe unmet medical need. Alveron’s drug OKL-1111 strongly reduces hematoma expansion in a mouse model of intracranial hemorrhage. As an injection solution that is ready to use, OKL-1111 is being developed to do away with a laborious pre-treatment process. | $4.5M | Seed | Oct 11, 2021 |  |
| Spartan Radar | Spartan’s proprietary software algorithms leverage machine learning and edge-processing to provide high-resolution sensing that mimics the human ability of instantly shifting focus to safely respond to obstacles. Spartan works with existing ADAS sensors to increase resolution, response time, and range. Our software increases sensing performance atan affordable cost with low computational overhead. Signal processing expertise built over decades of commercializing aerospace and automotive technologies | $10M | Seed | Aug 26, 2021 |  |

10 of 11 investments shown.

## Co-investors
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 3 deals together
- [aMoon Fund](https://shizune.co/investors/profile/amoon) — VC Fund, 3 deals together
- [Catalio Capital Management](https://shizune.co/investors/profile/catalio-capital-management) — VC Fund, 2 deals together
- [FORWARD.one](https://shizune.co/investors/profile/forward-one) — VC Fund, 2 deals together
- [InnovationQuarter](https://shizune.co/investors/profile/innovation-quarter) — VC Fund, 2 deals together
- [Lightspeed Venture Partners](https://shizune.co/investors/profile/lightspeed-venture-partners) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Waterman Ventures invest in?

Waterman Ventures invests primarily in Software, Biopharma and Biotechnology startups, most often at Seed and Series A stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Waterman Ventures?

Public channels for Waterman Ventures include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Waterman Ventures?

The team at Waterman Ventures includes Dave Fan (Senior Principal, Investment Committee Member), Dave Fan (Senior Principal, Investment Committee Member) and Lawrence Ham (Fellow). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co